Global Albumin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Albumin market size was valued at US$ 7087 million in 2024 and is forecast to a readjusted size of USD 10800 million by 2031 with a CAGR of 6.3% during review period.
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
The albumin market is driven by the rising prevalence of liver diseases, kidney disorders, and hypoproteinemia, which require albumin therapy. Additionally, the growing use of albumin in critical care, such as treating burns, shock, and sepsis, is fueling demand. Expanding applications in drug delivery, vaccine formulation, and regenerative medicine are also key factors driving market growth. Moreover, the increasing geriatric population and advancements in recombinant and synthetic albumin production are expected to boost market expansion, particularly in developed healthcare markets.
However, the market faces challenges such as high production costs and supply constraints, particularly for human serum albumin, which relies on plasma collection. Stringent regulatory approvals for plasma-derived products and concerns regarding pathogen transmission further hinder market growth. Additionally, competition from alternative therapies, including synthetic colloids and plant-based albumin substitutes, may impact demand. Market players must address supply chain limitations, invest in recombinant albumin production, and navigate complex regulatory landscapes to sustain growth in this competitive industry.
This report is a detailed and comprehensive analysis for global Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Albumin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Albumin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Market segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
Major players covered
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Sartorius
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Thermo Fisher
Merck
Cytiva
Proliant Biologicals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin, with price, sales quantity, revenue, and global market share of Albumin from 2020 to 2025.
Chapter 3, the Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin.
Chapter 14 and 15, to describe Albumin sales channel, distributors, customers, research findings and conclusion.
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
The albumin market is driven by the rising prevalence of liver diseases, kidney disorders, and hypoproteinemia, which require albumin therapy. Additionally, the growing use of albumin in critical care, such as treating burns, shock, and sepsis, is fueling demand. Expanding applications in drug delivery, vaccine formulation, and regenerative medicine are also key factors driving market growth. Moreover, the increasing geriatric population and advancements in recombinant and synthetic albumin production are expected to boost market expansion, particularly in developed healthcare markets.
However, the market faces challenges such as high production costs and supply constraints, particularly for human serum albumin, which relies on plasma collection. Stringent regulatory approvals for plasma-derived products and concerns regarding pathogen transmission further hinder market growth. Additionally, competition from alternative therapies, including synthetic colloids and plant-based albumin substitutes, may impact demand. Market players must address supply chain limitations, invest in recombinant albumin production, and navigate complex regulatory landscapes to sustain growth in this competitive industry.
This report is a detailed and comprehensive analysis for global Albumin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Albumin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Albumin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Albumin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2020-2031
Global Albumin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Albumin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Albumin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Albumin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Market segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
Major players covered
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Sartorius
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Thermo Fisher
Merck
Cytiva
Proliant Biologicals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Albumin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Albumin, with price, sales quantity, revenue, and global market share of Albumin from 2020 to 2025.
Chapter 3, the Albumin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Albumin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Albumin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Albumin.
Chapter 14 and 15, to describe Albumin sales channel, distributors, customers, research findings and conclusion.
Table of Contents
143 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Albumin by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
